Your browser doesn't support javascript.
loading
The Outcome of Locally Advanced Cervical Cancer in Patients Treated with Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Primary Surgery.
Mousavi, Azamsadat; Modarres Gilani, Mitra; Akhavan, Setareh; Sheikh Hasani, Shahrzad; Alipour, Abbas; Gholami, Hamideh.
Afiliación
  • Mousavi A; Department of Oncology, Emam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Modarres Gilani M; Department of Oncology, Emam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Akhavan S; Department of Oncology, Emam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Sheikh Hasani S; Department of Oncology, Emam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Alipour A; Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
  • Gholami H; Department of Oncology, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
Iran J Med Sci ; 46(5): 355-363, 2021 09.
Article en En | MEDLINE | ID: mdl-34539010
Background: In recent years, before radical hysterectomy, neoadjuvant chemotherapy (NACT) has been administered to patients with locally advanced cervical cancer to shrink large tumors. It has been reported that this treatment significantly reduces the need for radiotherapy after surgery. The current study aimed to assess the outcome (survival, recurrence, and the need for adjuvant radiotherapy) of locally advanced cervical cancer in patients treated with NACT followed by radical hysterectomy and primary surgery. Methods: In a retrospective cohort study, the records of 258 patients with cervical cancer (stage IB2, IIA, or IIB), who referred to Imam Khomeini Hospital (Tehran, Iran) from 2007 to 2017 were evaluated. The patients were assigned into two groups; group A (n=58) included patients, who underwent radical hysterectomy and group B (n=44) included those, who underwent a radical hysterectomy after NACT. The outcome measures were the recurrence rate, five-year survival rate, and the need for adjuvant radiotherapy. Results: The median for overall survival time in group A and B was 113.65 and 112.88 months, respectively (P=0.970). There was no recurrence among patients with stage IB2 cervical cancer in group B, while the recurrence rate in group A was 19.5% with a median recurrence time of 59.13 months. Lymph node involvement was the only factor that affected patients' survival. The need for postoperative adjuvant radiotherapy in group B was lower than in group A (P=0.002). Conclusion: NACT before the hysterectomy was found to reduce the need for postoperative radiotherapy in patients with locally advanced cervical cancer according to disease stages. As a direct result, adverse side effects and the recurrence rate were reduced, and the overall survival rate of patients with stage IIB cervical cancer was increased.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Evaluación de Resultado en la Atención de Salud / Terapia Neoadyuvante / Histerectomía Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Iran J Med Sci Año: 2021 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Evaluación de Resultado en la Atención de Salud / Terapia Neoadyuvante / Histerectomía Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Iran J Med Sci Año: 2021 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán